Document Detail


Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
MedLine Citation:
PMID:  16167426     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although cutaneous reactions from antineoplastic therapy are common, a reticulate pattern of hyperpigmentation has not been frequently reported in the literature. We report 2 cases of reticulate hyperpigmentation associated with cancer chemotherapy with 5-fluorouracil and idarubicin. These 2 cases serve to raise awareness of this particular pattern of hyperpigmentation as a potential side effect of chemotherapeutic regimens.
Authors:
Reena Jogi; Mary Garman; Josie Pielop; Ida Orengo; Sylvia Hsu
Related Documents :
22937376 - The fourth branchial complex anomaly: a rare clinical entity.
10110876 - Review effect on cost reports: impact smaller than anticipated.
19851916 - Comparing computer-tailored, internet-based smoking cessation counseling reports with g...
9220656 - Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic le...
7197126 - The fetal alcohol syndrome in japan.
17506086 - Constructing insanity: jurors' prototypes, attitudes, and legal decision-making.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  4     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:    2005 Sep-Oct
Date Detail:
Created Date:  2005-09-19     Completed Date:  2005-10-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  652-6     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibiotics, Antineoplastic / adverse effects*,  therapeutic use
Antimetabolites, Antineoplastic / adverse effects*,  therapeutic use
Carcinoma, Squamous Cell / complications,  drug therapy
Cytarabine / therapeutic use
Female
Fluorouracil / adverse effects*,  therapeutic use
Humans
Hyperpigmentation / chemically induced*,  pathology*
Idarubicin / adverse effects*,  therapeutic use
Leukemia, Myeloid / complications,  drug therapy
Middle Aged
Parotid Neoplasms / complications,  drug therapy
Skin / pathology*
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/Antimetabolites, Antineoplastic; 147-94-4/Cytarabine; 51-21-8/Fluorouracil; 58957-92-9/Idarubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pancytopenia after a single intradermal infiltration of methotrexate.
Next Document:  Exploring nursing education in the People's Republic of China, Japan and Turkey.